The future impact of clinical pharmacy on parenteral drugs and the industry
Whitney, H.A.; Covington, T.R.
Bulletin of the Parenteral Drug Association 25(2): 87-97
1971
ISSN/ISBN: 0048-2986 PMID: 5563323 Document Number: 41544
Document emailed within 1 workday
Related Documents
Elliott, G.A. 1970: The impact of clinical trials of drugs on the investigator, the industry and the country South African Medical Journal 44(1): 5-7Lockwood, W.A. 1989: The impact of future technology on outpatient pharmacy Topics in Hospital Pharmacy Management 9(3): 37-41
Van der Vlerk, M. 1972: Clinical pharmacy: the future of our profession. 9 Pharmaceutisch Weekblad 107(16): M217-M221
Yang, Y.; Latkin, C.; Luan, R.; Yang, C. 2016: Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs International Journal on Drug Policy 27: 113-120
Tetzlaff, R.F. 1983: Systems validation for parenteral clinical drugs--application to R&D and QC laboratories Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 37(2): 45-50
Flack, H.L. 1971: Clinical pharmacy programs: case presentations, Philadelphia College of Pharmacy and Science American Journal of Hospital Pharmacy 28(11): 852-855
Gouveia, W.A. 1984: Hospital pharmacy and industry--conflict and collaboration American Journal of Hospital Pharmacy 41(7): 1391-1394
Vejraska, M.T.; Wiederholt, J.B.; Zilz, D.A. 1987: Qualifications for future hospital pharmacy directors as perceived by pharmacy directors and hospital administrators in Wisconsin American Journal of Hospital Pharmacy 44(7): 1606-1614
Agalloco, J.P. 1986: The use of consultants in the parenteral industry Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 40(6): 277-283
Wagler, M. 1970: Standardization as a basis planning and administration in drug industry and pharmacy (II) Pharmazeutische Praxis 7: 151-153
Koch, H. 1970: Standardization as a basis for planning and administration in drug industry and pharmacy (I) Pharmazeutische Praxis 7: 147-151
Allen, L.V. 1995: Drugs, devices and delivery considerations in parenteral pharmaceutical care, or, what are they doing with our drugs? PDA Journal of Pharmaceutical Science and Technology 49(6): 306-308
Zhan, W.-h.; Jiang, Z.-m.; Tang, Y.; Wu, Y.-p.; Liu, J.-w.; Zhang, Y.-j.; Chen, W.; Liu, T.; Yao, C. 2007: Impact of hypocaloric and hypo-nitrogen parenteral nutrition on clinical outcome in postoperative patients: a multi-center randomized controlled trial of 120 cases Zhonghua Yi Xue Za Zhi 87(25): 1729-1733
Latiolais, C.J. 1970: Implications of I V additive programs to the parenteral industry Bulletin of the Parenteral Drug Association 24(1): 45-51
Campbell, R.K. 1976: Distributive versus patient-oriented pharmacy: a pharmacy practice problem requiring a definition and solution by pharmacy faculty American Journal of Pharmacy and the Sciences Supporting Public Health 148(5): 148-150
Plumridge, R.J. 1981: Forecast of the future of hospital pharmacy in Australia American Journal of Hospital Pharmacy 38(10): 1469-1472
Tomioka, H.; Tada, A. 2010: Can we have adequate chemotherapy regimens for tuberculosis in the future? Current status and future prospects for development of new antituberculosis drugs Kekkaku: 85(2): 113-123
Parrish, R.H. 1979: Pharmacy intern/physician communication: training for future practice American Pharmacy 19(2): 51-52
Cowen, D.L.; Helfand, W.H. 1979: The progressive movement and its impact on pharmacy Pharmaceutica Acta Helvetiae 54(11): 317-323
Holsomback, T.C. 1985: The impact of risk management on hospital pharmacy Topics in Hospital Pharmacy Management 5(2): 53-62